Patent Yard Sign in
Canadian application, no grantCanada

Amide substituted imidazopyridines

CA 2468174 A1 · Owner: Dellaria, Joseph F. Jr. · Inventors: Lindstrom, Kyle J.; Dellaria, Joseph F. Jr.; Haraldson, Chad A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Imidazopyridine compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 7, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 7, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 7, 2002
GrantedNo grant recorded
Term endedJune 7, 2022
Patent numberCA 2468174 A1
Classification (IPC)C07D471/04 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 7, 2002Term endedJune 7, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.